Related references
Note: Only part of the references are listed.Targeted delivery of TLR ligands to human and mouse dendritic cells strongly enhances adjuvanticity
Paul J. Tacken et al.
BLOOD (2011)
Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A
Juliana Idoyaga et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Plasmacytoid dendritic cell-derived type I interferon is crucial for the adjuvant activity of Toll-like receptor 7 agonists
Deepa Rajagopal et al.
BLOOD (2010)
HIV gag protein is efficiently cross-presented when targeted with an antibody towards the DEC-205 receptor in Flt3 ligand-mobilized murine DC
Leonia Bozzacco et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Targeted PLGA nano- but not microparticles specifically deliver antigen to human dendritic cells via DC-SIGN in vitro
Luis J. Cruz et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8α+ dendritic cells
Lionel Franz Poulin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Route of Antigen Uptake Differentially Impacts Presentation by Dendritic Cells and Activated Monocytes
Alice O. Kamphorst et al.
JOURNAL OF IMMUNOLOGY (2010)
The Human Cancer Antigen Mesothelin Is More Efficiently Presented to the Mouse Immune System when Targeted to the DEC-205/CD205 Receptor on Dendritic Cells
Bei Wang et al.
CANCER VACCINES (2009)
Triggering TLR7 in mice induces immune activation and lymphoid system disruption, resembling HIV-mediated pathology
Stefan Baenziger et al.
BLOOD (2009)
Enhancing immune responses by targeting antigen to DC
Irina Caminschi et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Polyl:C-induced reduction in uptake of soluble antigen is independent of dendritic cell activation
Inigo Tirapu et al.
INTERNATIONAL IMMUNOLOGY (2009)
Targeting the nuclear antigen I of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses
Cagan Gurer et al.
BLOOD (2008)
The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement
Irina Caminschi et al.
BLOOD (2008)
Inhibition of Melanoma Growth by Targeting of Antigen to Dendritic Cells via an Anti-DEC-205 Single-Chain Fragment Variable Molecule
Theron S. Johnson et al.
CLINICAL CANCER RESEARCH (2008)
Excessive CpG 1668 stimulation triggers IL-10 production by cDC that inhibits XFN-α responses by pDC
Zoe Waibler et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Determination of T-cell fate by dendritic cells
Sandra S. Diebold
IMMUNOLOGY AND CELL BIOLOGY (2008)
Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin
David Sancho et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation
Sven Burgdorf et al.
NATURE IMMUNOLOGY (2008)
The microbial mimic poly IC induces durable and protective CD4+ T cell immunity together with a dendritic cell targeted vaccine
Christine Trumpfheller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists
Holger Kanzler et al.
NATURE MEDICINE (2007)
Differential antigen processing by dendritic cell subsets in vivo
Diana Dudziak et al.
SCIENCE (2007)
Preferential induction of CD4+ T cell responses through in vivo targeting of antigen to dendritic cell-associated C-type lectin-1
Robert W. Carter et al.
JOURNAL OF IMMUNOLOGY (2006)
The mannose receptor mediates uptake of soluble but not of cell-associated antigen for cross-presentation
Sven Burgdorf et al.
JOURNAL OF IMMUNOLOGY (2006)
Toll-dependent selection of microbial antigens for presentation by dendritic cells
JM Blander et al.
NATURE (2006)
Induction of CD8+ T cell responses through targeting of antigen to Dectin-2
Robert W. Carter et al.
CELLULAR IMMUNOLOGY (2006)
Systemic administration of a TLR7 ligand leads to transient immune incompetence due to peripheral-blood leukocyte depletion
M Gunzer et al.
BLOOD (2005)
Targeting of antigens to activated dendritic cells in vivo cures metastatic melanoma in mice
K Mahnke et al.
CANCER RESEARCH (2005)
Single chain antibody fragments for the selective targeting of antigens to dendritic cells
C Demangel et al.
MOLECULAR IMMUNOLOGY (2005)
Cutting edge: Species-specific TLR9-mediated recognition of CpG and non-CpG phosphorothioate-modified ohgonucleotides
TL Roberts et al.
JOURNAL OF IMMUNOLOGY (2005)
In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination
LC Bonifaz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration
M Heikenwalder et al.
NATURE MEDICINE (2004)
Targeting dendritic cells with antigen-containing liposomes: A highly effective procedure for induction of antitumor immunity and for tumor immunotherapy
CL van Broekhoven et al.
CANCER RESEARCH (2004)
Most lymphoid organ dendritic cell types are phenotypically and functionally immature
NS Wilson et al.
BLOOD (2003)
Toll-like receptor expression in murine DC subsets:: lack of TLR7 expression by CD8α+ DC correlates with unresponsiveness to imidazoquinolines
AD Edwards et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
Toll-like receptor 9 expression is not required for CpG DNA-aided cross-presentation of DNA-conjugated antigens but essential for cross-priming of CD8 T cells
A Heit et al.
JOURNAL OF IMMUNOLOGY (2003)
Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance
L Bonifaz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848
M Jurk et al.
NATURE IMMUNOLOGY (2002)
Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo
D Hawiger et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
The role of the macrophage scavenger receptor in immune stimulation by bacterial DNA and synthetic oligonucleotides
FG Zhu et al.
IMMUNOLOGY (2001)
Immunostimulatory DNA-based vaccines induce cytotoxic lymphocyte activity by a T-helper cell-independent mechanism
HJ Cho et al.
NATURE BIOTECHNOLOGY (2000)
Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets
RA Clynes et al.
NATURE MEDICINE (2000)
Rapid antibody responses by low-dose, single-step, dendritic cell-targeted immunization
H Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
